Kyle Gano - Chief Executive Officer, Director at NEUROCRINE BIOSCIENCES INC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
NBIX on Nasdaq
All Insider Reports
All Insider Reports

Kyle Gano - trading volume in the past year for NEUROCRINE BIOSCIENCES INC

Holdings reported by Kyle Gano for NEUROCRINE BIOSCIENCES INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 150,815 $18,719,157 $124.12 13 Feb 2026 Direct
Restricted Stock Unit 20,142 $784,951 $116.72 13 Feb 2026 Direct Common Stock
Incentive Stock Option 0 $0 $43.24 16 Jan 2026 Direct Common Stock
Non-Qualified Stock Option 0 $0 $73.60 16 Jan 2026 Direct Common Stock
Stock Option 114,830 13 Feb 2026 Direct Common Stock

Transactions reported by Kyle Gano for NEUROCRINE BIOSCIENCES INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.